Skip to content

Anxiety: all studies

Page 142 of 769: studies 1,411 to 1,420 of 7,689, newest first. Back to the anxiety overview

Research

0730 EFFECT OF EVERYDAY ANXIETY AND PSYCHOLOGICAL WELL-BEING ON THE RECALL OF DISTURBED DREAMING

Sleep April 28, 2017 Cristina Banu, Pierre McDuff, Antonio Zadra 1 citation

The present study tested a prediction from Levin and Nielsen’s (2007) neurocognitive model of disturbed dreaming stipulating that variations in the frequency of bad dreams and nightmares are partly determined by day-to-day variations in emotional stress. The model also suggests that relations between dreams and stress may vary as a function of personality traits. 224 adults (186F, 38M, mean...

Characterizing the experiences of flotation-REST (Restricted Environmental Stimulation Technique) treatment for generalized anxiety disorder (GAD): A phenomenological study

European Journal of Integrative Medicine April 28, 2017 Kristoffer Jonsson, Anette Kjellgren 15 citations

Among the anxiety disorders Generalized Anxiety Disorder (GAD) is currently the most treatment resistant, suggesting that treatment protocols could be enhanced. A promising treatment of GAD is flotation-REST (Restricted Environmental Stimulation Technique), which in earlier studies has been shown to alleviate symptoms in GAD. Although, research on flotation-REST as a treatment of GAD has shown...

DOI: 10.1016/j.eujim.2017.04.011 (opens in new tab) Generalized anxiety disorder Psychotherapist Rest music Clinical psychology +3

The influence of a mindfulness-based intervention on job satisfaction and work-related stress and anxiety

April 20, 2017 N. Wongtongkam, Branka Krivokapic‐Skoko, R. Duncan et al.

Abstract Workplace mindfulness is a recognised tool for enhancing health and well-being of university staff and may result in better task performance and satisfaction in the workplace. The study examined the beneficial effects of mindfulness meditation on job satisfaction, mindful awareness and anxiety levels in university personnel. Mixed methods with a quasi-experiment and in-depth interviews...

Does Intra-ICU Initiation of Guided Mindfulness Meditation Decrease Anxiety and Depression in SAH?: A Unique Methodology for the Neurocritical Care Setting (P5.069)

Neurology April 18, 2017 D. Wheelwright, N. Dangayach, Stephen Griffiths et al.

Objective: We hypothesize that intra-ICU initiation of guided mindfulness meditation is feasible and will help prevent the development of anxiety and depression in good grade SAH patients. Background: Aneurysmal Subarachnoid Hemorrhage (SAH) has a case fatality rate of about 20%. Of all SAH patients, 40% are “good grade” defined as Hunt-Hess 1–2 with normal mental status whereas 60% are poor...

Reducing anxiety, geriatric depression and worry in a sample of older adults through a mindfulness training program

April 1, 2017 C. Franco, Alberto Amutio, Israel Mañas et al.

This study aimed to analyze the effects of a mindfulness training program on anxiety, worry, and geriatric depression in a sample of older adults. A randomized controlled trial with pretest-posttest measurements was used on an experimental group (n = 42) and a control group (waiting list; n = 45). Participants in the experimental group completed the Short Cognitive Examination, the Penn State...

Effects of mindfulness meditation on occupational functioning and health care utilization in individuals with anxiety.

Journal of Psychosomatic Research April 2017 Elizabeth A Hoge, Brittany M. Guidos, Mihriye Mete et al.

To examine the effect of mindfulness meditation on occupational functioning in individuals with Generalized anxiety disorder (GAD). Fifty-seven individuals with GAD (mean (SD) age=39 (13); 56% women) participated in an 8-week clinical trial in which they were randomized to mindfulness-based stress reduction (MBSR) or an attention control class. In this secondary analysis, absenteeism, entire...

DOI: 10.1016/j.jpsychores.2017.01.011 (opens in new tab) Full text (opens in new tab) Anxiety Absenteeism Clinicaltrials.gov identifier Health care utilization +2

Intramuscular ketamine in depression, suicidal thoughts and anxiety: A report on two cases

European Psychiatry April 1, 2017 M. Cigognini, R. Moreno

Introduction: Several studies have shown that ketamine, an antagonist of NMDA receptors, represents a promising alternative in the treatment of depression. The therapeutic use of ketamine, commonly used at a dose of 0.5 mg/kg, and in a single application IV has been short and requires monitoring in a hospital setting. IM use has been shown to be effective in treating depression and suicide...

The effectiveness of mindfulness-based stress reduction (MBSR) in anxiety and depression in patients with multiple sclerosis (MS)

European Psychiatry April 1, 2017 E. Alisaleh, S. Ghahari

ObjectiveThe main objective of the present study is to investigate effectiveness of mindfulness-based stress reduction in anxiety and depression in patients with multiple sclerosis.MethodsThis study is in kind of semi-experimental research in form of pretest–posttest pattern with control group. Statistical population of the study consists of all patients with multiple sclerosis referred to Iran...

The Role of Rajyoga Meditation for Modulation of Anxiety and Serum Cortisol in Patients Undergoing Coronary Artery Bypass Surgery: A Prospective Randomized Control Study

Annals of Cardiac Anaesthesia April 1, 2017 U. Kiran, Suruchi Ladha, N. Makhija et al.

Introduction: Rajyoga meditation is a form of mind body intervention that is promoted by the Brahma Kumaris World Spiritual University. This form of meditation can be easily performed without rituals or mantras and can be practiced anywhere at any time. The practice of Rajyoga meditation can have beneficial effects on modulating anxiety and cortisol level in patients undergoing major cardiac...

Anxiety, panic, and hopelessness during and after ritual ayahuasca intake in a woman with generalized anxiety disorder: A case report

Journal of Psychedelic Studies April 1, 2017 Rafael G. Dos Santos, Flávia de Lima Osório, José Alexandre S. Crippa et al. 7 citations

Ayahuasca is a dimethyltryptamine- and β-carboline-rich hallucinogenic beverage traditionally used by indigenous groups of Northwest Amazonian for ritual and therapeutic purposes. Animal and human studies suggest that ayahuasca has antidepressant and anxiolytic potentials and has a good safety profile. However, anxiety-like reactions may also occur after ayahuasca intake, although they are...